Adopting this pathways approach, the present metabolomic study focused on the metabolism of phenylalanine through L-phenylalanine ammonia lyase (PAL) and phenylalanine hydroxylase (PAH), and their possible relationship with L-tryptophan and its metabolites in PD patients, compared to reference, non-PD, controls. Here, PAH is linked to Parkinson disease.